Backgrounds/Aims: Although laparoscopic cholecystectomy is a common and widely accepted technique, the use of prophylactic antibiotics in elective laparoscopic cholecystectomy still remains controversial. The aim of this study is to determine whether prophylactic antibiotics could prevent surgical site infection after elective laparoscopic cholecystectomy and to identify any risk factors for surgical site infection. Methods: This study included 471 patients undergoing laparoscopic cholecystectomy between January 2009 and May 2012. Period 1 patients (279) received second generation cephalosporin 1 g intravenously after induction of anesthesia, and Period 2 patients (192) were not given prophylactic antibiotics. The characteristics and surgical site infections of the patients were compared and analyzed. Results: The overall rate of surgical site infection was 1.69% for the total of 471 patients. The incidence of surgical site infection was similar for the two Periods: 5 of 279 patients (1.79%) in Period 1, 3 of 192 patients (1.56%) in Period 2 (p=0.973). All of the patients with surgical site infections were well treated under conservative treatments without any sequelae. The preoperative albumin level (p=0.023) contributed to surgical site infection. Conclusions: Prophylactic antibiotics are not necessary for elective laparoscopic cholecystectomy but patients in poor nutritional state with low albumin level should consider prophylactic antibiotics. 
INTRODUCTION
Laparoscopic cholecystectomy (LC) has been the gold standard treatment for symptomatic gallstone disease since 1990. 1, 2 The main advantages of LC include less postoperative pain, shorter hospital stays, lower morbidity and mortality, and a lower rate of postoperative infection. Out of the several advantages over open cholecystectomy, an important benefit is the low rate of infective complications (0.4% to 1.1%), mostly occurring at the umbilical port site. 3 Because of the low risk of infection, there have been many debates on whether prophylactic antibiotics are necessary.
Currently, many randomized controlled trials (RCTs)
have not been able to show any benefit of prophylactic antibiotics in low risk LC. [4] [5] [6] However, the statistical power in RCTs has been questioned in some reports, many meta-analysis results do not recommend prophylactic antibiotics in low risk LC as well. 3, [7] [8] [9] [10] [11] Therefore, more recent guidelines on surgical site infection (SSI) from the Scottish
Intercollegiate Guidelines Network (SIGN) and American
Society of Health-System Pharmacists (ASHP) do not recommend prophylactic antibiotics in low risk elective LC. 12, 13 But prophylactic antibiotics are still recommended for the high-risk group.
On the other hand, Matsui et al. 14 15 With a new guideline by CDC on the way, the role of prophylactic antibiotics should be carefully analyzed with well-gathered data.
The aim of this study was to determine whether prophylactic antibiotics could prevent surgical site infection after elective LC and to identify the high-risk group for SSI.
MATERIALS AND METHODS
We retrospectively reviewed medical records of 534 All patients underwent operation by a single surgeon.
LC was performed using 3-port placements in all cases.
A transverse supraumbilical incision was made and a 12 mm camera port was introduced using a Veress needle.
Two additional 5 mm working ports were placed under direct vision in the right subcostal and subxiphoid areas.
Examination for SSI was made until hospital discharge and again at the first postoperative visit. All patients were followed up within 7 days from the discharge in the outpatient department and again in 2 months. Postoperative
SSIs were defined according to the CDC guidelines. included in the definition. 15 Deep incisional SSI was defined to be an infection involving deep soft tissues of the incision; and organ/space SSI was defined to be an infection involving any part of body deeper than the fascial/muscle layers, that is manipulated during the operation. 15 According to the definition of the CDC guidelines, a stitch abscess alone with minimal inflammation and discharge confined to the points of suture penetration was not considered a SSI. In a case of SSI, the standard management of wound care was provided: including antibiotics, dressing, or intervention drainage. The results of AST and ALT values showed normal liver functions prior to operation and mean bilirubin level in both periods were within normal range. Preoperative laboratory results were compared between the periods and the results also showed no significant difference (Table 2) .
Statistical analysis
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Postoperative results
The mean length of hospital stay during period 1 was 2.7±1.9 days and 2.9±1.5 days for period 2 (p=0.882).
The total operation time during the two periods was similar with 51.0±52.9 minutes for period 1 and 50.3±40.9 minutes for period 2 (p=0.154). Intraoperative gallbladder perforation also occurred at a similar rate in both periods Postoperative results did not show significant results between the two periods, including mean length of hospital stay, operation time and intraoperative gallbladder perforation (Table 3) .
Incidences of surgical site infection
The incidences of SSIs are shown in Table 3 . Five But, intraoperative cholangiogram is considered to be a high-risk only in the SIGN guideline. In the therapeutic guideline by ASHP, the high-risk factors for SSI are considered to be: emergency procedures, diabetes, long procedure duration, age ＞70 years, ASA score of 3 or higher,
and an episode of colic within 30 days before the procedure.
These discrepancies in the definition of a high-risk group should be addressed in future studies. Furthermore, our data have also shown nutritional state, in terms of albumin level, as a risk factor for SSI. The preoperative albumin level was similar between the groups, but patients with a higher preoperative albumin level were at a lower risk of SSIs.
Although our data could not confirm the high-risk variables from these guidelines, it is noteworthy to consider nutritional state as a possible risk factor in SSI for LC; thus further evaluation is warranted.
The main limitation of this study includes the lack of statistical power to overcome the type II error. With the incidences of reported SSIs at less than 2%, to have a significance power of 80% and lower limit of a 2-sided 95% confidence interval, more than 4,000 patients are necessary.
Our study was based on a single surgeon experience with the intention of properly assessing SSIs to reduce underreporting and compensate for this limitation. Nevertheless, results of low SSI rates in both groups suggest that further study with a sufficiently powered sample size may have a limited value.
When the Center for Disease Control (CDC) first introduced its guideline on SSI in 1999, SSI was reported to be third most common nosocomial infection, accounting for 14 to 16%. 16 Since then, many advances have been made in infection control practices. However, the most current definition of SSI by CDC states that SSI is now the most common HAIs, which accounts for 31%. 15 Surveillance of SSI has been emphasized in the reduction of SSI risk. With the new CDC guideline on SSI expected soon, definition and surveillance protocol for SSI are being updated. With recent modifications in surveillance of SSI and more awareness, a more refined classification is recommended in the effort to reduce SSIs.
In conclusion, we could not find a benefit of prophylactic antibiotics on surgical site infection in laparoscopic cholecystectomy. SSIs were not associated with an increase in length of hospital stay and patients were well treated with conservative care in the outpatient department.
Prophylactic antibiotics are not necessary for elective LC, but patients in poor nutritional state with low albumin level should consider prophylactic antibiotics.
